2009-11-10 02:07:03 - Endo Pharmaceuticals Holdings Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com

www.companiesandmarkets.com/Summary-Company-Profile/endo-pharmac ..

Endo Pharmaceuticals Holdings Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Endo Pharmaceuticals Holding Inc. (Endo) is a pharmaceutical company focused on the research, development and commercialization of branded and generic prescription pharmaceuticals to treat pain principally in the US. Its banded product portfolio includes Frova, Lidoderm, Opana, Opana Er, Percocet, Percodan, Voltaren Gel, Moban, Endocet, Endodan, Morphine Sulfate

and Zydone. The company is headquartered in Pennysylvania, United States. On March 23, 2009, Endo Pharmaceuticals completed the acquisition of Indevus Pharmaceuticals, Inc. Following the acquisition, Indevus Pharmaceuticals became a wholly owned subsidiary of Endo

The Endo Pharmaceuticals Holdings Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals.

Scope

- Provides key company information for business intelligence needs
- Gives information on the company’s major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Reasons to buy

- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers’ businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors’ business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.